BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//DataCutoff//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:DataCutoff · $000100.KS readouts
X-WR-CALDESC:Clinical-trial primary completion dates from ClinicalTrials.go
 v\, refreshed nightly by DataCutoff. Not investment advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07415551-pcd@datacutoff.com
DTSTAMP:20261118T142521Z
DTSTART;VALUE=DATE:20270619
DTEND;VALUE=DATE:20270620
SUMMARY:CLEAR readout (P2) · Yuhan Corporation $000100.KS
DESCRIPTION:Phase 2 Study of Lesigercept in Adult Patients With Chronic Spo
 ntaneous Urticaria Who Are Inadequately Controlled by H1-Antihistamines\n\
 nPrimary completion date: 2027-06-19 (estimated)\nPhase 2 · Immuno · All
 ergic Diseases\, Chronic Spontaneous Urticaria (CSU)\nEnrollment: 150 · S
 ites: 30\n\nPrimary completion = last participant's primary-endpoint data 
 collected\; topline results usually follow weeks to months later. Sponsor-
 reported\, often an estimate. Not investment advice.\n\nhttps://datacutoff
 .com/radar.html?nct=NCT07415551\nhttps://clinicaltrials.gov/study/NCT07415
 551
URL:https://datacutoff.com/radar.html?nct=NCT07415551
CATEGORIES:Immuno,Phase 2
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
